Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Prista Charuworn"'
Autor:
Jie Zhang, Peter Yu, Ying Bao, Cathy W Critchlow, Corina Bennett, Fang He, Julia Zhu, Zhongyuan Wei, Qian Xia, Jenny Jiang, Olulade Ayodele, Brian D Bradbury, Corinne Brooks, Carolyn A Brown, Alvan Cheng, Giovanna Devercelli, Kathleen Gondek, Ajit A Londhe, Junjie Ma, Michele Jonsson-Funk, Hillary A Keenan, Kaili Ren, Lynn Sanders, Linyun Zhou, John H Page, J Michael Sprafka, Megan Braunlin, Prista Charuworn, Karminder Gill, Jeffrey Petersen, Katherine B Carlson, Shun-Chiao Chang, Kimberly A Roehl, Luyang Wang
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/8d862731349f4c36b3e1599111849ac7
Autor:
John H Page, Ajit A Londhe, Corinne Brooks, Jie Zhang, J Michael Sprafka, Corina Bennett, Megan Braunlin, Carolyn A Brown, Prista Charuworn, Alvan Cheng, Karminder Gill, Fang He, Junjie Ma, Jeffrey Petersen, Olulade Ayodele, Ying Bao, Katherine B Carlson, Shun-Chiao Chang, Giovanna Devercelli, Michele Jonsson-Funk, Jenny Jiang, Hillary A Keenan, Kaili Ren, Kimberly A Roehl, Lynn Sanders, Luyang Wang, Zhongyuan Wei, Qian Xia, Peter Yu, Linyun Zhou, Julia Zhu, Kathleen Gondek, Cathy W Critchlow, Brian D Bradbury
Publikováno v:
BMJ Open. 12:e055137
ObjectivesTo examine the temporal patterns of patient characteristics, treatments used and outcomes associated with COVID-19 in patients who were hospitalised for the disease between January and 15 November 2020.DesignObservational cohort study.Setti
Autor:
Priti Patel, Jennifer A. Woyach, Raquel Izumi, Richard R. Furman, Peter Hillmen, Ahmed Hamdy, Prista Charuworn, Jennifer R. Brown, Elena Bibikova, John M. Pagel, Deborah M. Stephens, Min Hui Wang, Farrukh T. Awan, Bolan Linghu, Melanie M. Frigault, Anna Schuh, John C. Byrd
The Bruton tyrosine kinase (BTK) inhibitor ibrutinib improves patient outcomes in chronic lymphocytic leukemia (CLL); however, some patients experience adverse events (AEs) leading to discontinuation. Acalabrutinib is a potent, covalent BTK inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc6bd1edf0ce7856814aa1698875621
https://europepmc.org/articles/PMC6517672/
https://europepmc.org/articles/PMC6517672/
Autor:
John F. Flaherty, G. Mani Subramanian, Kathryn M. Kitrinos, Edward Gane, Sing Chan, Maria Buti, Prista Charuworn, Mary Kay Washington, Huy N. Trinh, Samuel S. Lee, Naoky Tsai, Phillip Dinh, Patrick Marcellin
Publikováno v:
Digestive Diseases and Sciences. 60:260-268
Chronic hepatitis B (CHB) is a major public health concern, particularly in endemic areas like Asia–Pacific. Sustained virologic suppression correlates with regression of histologic fibrosis and cirrhosis. This study evaluated efficacy and safety o
Autor:
Simone I. Strasser, Sang Hoon Ahn, G. B. Gaeta, Patrick Marcellin, Magdy Elkhashab, Seng Gee Lim, Jörg Petersen, Didier Samuel, Fehmi Tabak, Eduardo B. Martins, Xiaoli Ma, Won Young Tak, F.A. Caruntu, Prista Charuworn, Wan-Lung Chuang, Graham R. Foster, L. Morano, Leland J. Yee, R. Mehta, George V. Papatheodoridis, L. Lin, Robert Flisiak, Aric J. Hui, Scott Fung, Hung Chan, Maria Buti, Chuan-Mo Lee, Kosh Agarwal, Ramazan Idilman, G. Wu
Background: In patients with chronic hepatitis B, tenofovir disoproxil fumarate (TDF) plus pegylated interferon (PEG-IFN) for 48-weeks results in higher rates of hepatitis B surface antigen (HBsAg) loss than either monotherapy. Aim: To identify basel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54c5f28565f2e0a0899660749ab7f8f
http://hdl.handle.net/11591/368693
http://hdl.handle.net/11591/368693
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 6:217-227
HCV infection is a key cause of liver disease and a worldwide health problem. The authors of this Review discuss the HCV life cycle and the mechanisms that enable the virus to evade host immune mechanisms and persist within the host. Improved underst
Autor:
Ramsey Cheung, Prista Charuworn
Publikováno v:
Expert Opinion on Medical Diagnostics. 2:303-314
Background: Accurate diagnosis and characterization of hepatitis viruses are essential from a public health perspective and for clinical management. Objective: To review recent advances in the diagnosis of viral hepatitis A – D and their clinical u
Autor:
John F. Flaherty, Maria Buti, G. Mani Subramanian, Joerg Petersen, Zahary Krastev, Kathryn M. Kitrinos, Robert Flisiak, Selim Gürel, Edward Gane, Prista Charuworn, Patrick Marcellin, Naoky Tsai, Raul Aguilar Schall, Eduardo B. Martins
Publikováno v:
Digestive Diseases and Sciences
Background Long-term tenofovir disoproxil fumarate (TDF) treatment for chronic hepatitis B (CHB) is associated with sustained viral suppression and regression of fibrosis and cirrhosis at year 5 (240 weeks) and no TDF resistance through 6 years (288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d57228acf5532a28321ddbd97c0541d
http://hdl.handle.net/11452/26360
http://hdl.handle.net/11452/26360
Autor:
Fabien Zoulim, Paul N. Hengen, Hendrik W. Reesink, Dongliang Ge, Phillip Dinh, Raul Aguilar Schall, Prista Charuworn, Kathryn M. Kitrinos, Amoreena Corsa
Publikováno v:
Journal of hepatology, 62(5), 1033-1039. Elsevier
Background and Aims HBsAg loss is a desired, but rare, treatment-induced clinical endpoint in chronic hepatitis B (CHB). Few studies have evaluated viral factors contributing to HBsAg loss. Methods This study evaluated baseline interpatient sequence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4da2a4b77fc434166296fc9aa757bb1
https://pure.amc.nl/en/publications/baseline-interpatient-hepatitis-b-viral-diversity-differentiates-hbsag-outcomes-in-patients-treated-with-tenofovir-disoproxil-fumarate(78736543-f0d5-4aa2-acd8-818c816b390f).html
https://pure.amc.nl/en/publications/baseline-interpatient-hepatitis-b-viral-diversity-differentiates-hbsag-outcomes-in-patients-treated-with-tenofovir-disoproxil-fumarate(78736543-f0d5-4aa2-acd8-818c816b390f).html
Autor:
Lanjia Lin, Magdy Elkhashab, Scott Fung, Simone I. Strasser, J.G. McHutchinson, G.M. Subramanian, Wan-Lung Chuang, Chuan-Mo Lee, Georgios Papatheodoridis, Kosh Agarwal, Graham R. Foster, Jörg Petersen, Aric J. Hui, Didier Samuel, Won Young Tak, Ramazan Idilman, M. Buti, Seng Gee Lim, F.A. Caruntu, Robert Flisiak, G. B. Gaeta, H.L. Chan, L. Morano, R. Mehta, Fehmi Tabak, Eduardo B. Martins, Phillip Dinh, Patrick Marcellin, Prista Charuworn, Sung-Ku Ahn, Xiaoli Ma
Publikováno v:
Journal of Hepatology. 62:S251-S252